First case of mother-to-infant HIV type 1 group O transmission and evolution of C2V3 sequences in the infected child

被引:16
作者
Chaix-Baudier, ML
Chappey, C
Burgard, M
Letourneur, F
Igual, J
Saragosti, S
Rouzioux, C
机构
[1] Hop Necker Enfants Malad, Virol Lab, F-75015 Paris, France
[2] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA
[3] Inst Cochin Genet Mol, F-75014 Paris, France
[4] Hop Laennec, Serv Pneumol, F-75007 Paris, France
关键词
D O I
10.1089/aid.1998.14.15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report the first case of mother-to-infant transmission and follow-up for an HIV-1 group O virus from Cameroon, Isolates were obtained from the mother at delivery and from the child at birth and when 16 and 30 months old, We analyzed the viral evolution within mother and child by examining 51 sequences spanning C2V3 regions of the viral envelope gene, The mother carried two genotypes, vl and v2, The genotype vl was dominant in the child at birth, and persisted as a minor genotype at age 30 months, The genotype v2 was absent in the child sequences, The variability of the nucleotide sequences of the isolates from the child increased with age from 0.8 to 6%, and a novel genotype (v3) appeared at age 30 months, The nonsynonymous-to-synonymous mutation ratio increased with the age of the child, from 0.75 at birth to 1.86 at 30 months, indicating a high rate of fixation of amino acid changes in the child. The overall pattern was similar to that reported by Ganeshan et al.(1) (J Virol 1997;71:663-677) for group M viruses infecting child with a slow-developing form of the disease.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
[1]   GENETIC-ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE V3 REGION ISOLATES FROM MOTHERS AND INFANTS AFTER PERINATAL TRANSMISSION [J].
AHMAD, N ;
BAROUDY, BM ;
BAKER, RC ;
CHAPPEY, C .
JOURNAL OF VIROLOGY, 1995, 69 (02) :1001-1012
[2]   INFLUENCE OF CARBOHYDRATE MOIETIES ON THE IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GP160 [J].
BENJOUAD, A ;
GLUCKMAN, JC ;
ROCHAT, H ;
MONTAGNIER, L ;
BAHRAOUI, E .
JOURNAL OF VIROLOGY, 1992, 66 (04) :2473-2483
[3]   RELATION OF THE COURSE OF HIV-INFECTION IN CHILDREN TO THE SEVERITY OF THE DISEASE IN THEIR MOTHERS AT DELIVERY [J].
BLANCHE, S ;
MAYAUX, MJ ;
ROUZIOUX, C ;
TEGLAS, JP ;
FIRTION, G ;
MONPOUX, F ;
CIRARUVIGNERON, N ;
MEIER, F ;
TRICOIRE, J ;
COURPOTIN, C ;
VILMER, E ;
GRISCELLI, C ;
DELFRAISSY, JF ;
TARDIEU, M ;
NOSEDA, G ;
HURAUX, JM ;
LEVINE, M ;
VILMER, E ;
DECREPY, A ;
SIMON, F ;
KRIVINE, A ;
FRANCOUAL, C ;
DIMARIA, L ;
COURPOTIN, C ;
MONCOMBLE, CC ;
BURGARD, M ;
ROUZIOUX, C ;
GIRAULT, D ;
STEPHAN, JL ;
BLANCHE, S ;
TERRIS, J ;
VEBER, F ;
FIRTION, G ;
HENRION, R ;
CIRARUVIGNERON, N ;
BRUNER, C ;
MATHIEU, FP ;
HERVE, F ;
ALLISY, C ;
DANDINE, M ;
LABRUNE, P ;
VIAL, M ;
LACHASSINE, E ;
GAUDELUS, J ;
FLOCH, C ;
MAZY, F ;
MEIER, F ;
ROBIN, M ;
ALLEMON, MC ;
TALON, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (05) :308-312
[4]   A PROSPECTIVE-STUDY OF INFANTS BORN TO WOMEN SEROPOSITIVE FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
BLANCHE, S ;
ROUZIOUX, C ;
MOSCATO, MLG ;
VEBER, F ;
MAYAUX, MJ ;
JACOMET, C ;
TRICOIRE, J ;
DEVILLE, A ;
VIAL, M ;
FIRTION, G ;
DECREPY, A ;
DOUARD, D ;
ROBIN, M ;
COURPOTIN, C ;
CIRARUVIGNERON, N ;
LEDEIST, F ;
GRISCELLI, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (25) :1643-1648
[5]   THE USE OF VIRAL CULTURE AND P24-ANTIGEN TESTING TO DIAGNOSE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN NEONATES [J].
BURGARD, M ;
MAYAUX, MJ ;
BLANCHE, S ;
FERRONI, A ;
GUIHARDMOSCATO, ML ;
ALLEMON, MC ;
CIRARUVIGNERON, N ;
FIRTION, G ;
FLOCH, C ;
GUILLOT, F ;
LACHASSINE, E ;
VIAL, M ;
GRISCELLI, C ;
ROUZIOUX, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1192-1197
[6]   ISOLATION AND ENVELOPE SEQUENCE OF A HIGHLY DIVERGENT HIV-1 ISOLATE - DEFINITION OF A NEW HIV-1 GROUP [J].
CHARNEAU, P ;
BORMAN, AM ;
QUILLENT, C ;
GUETARD, D ;
CHAMARET, S ;
COHEN, J ;
REMY, G ;
MONTAGNIER, L ;
CLAVEL, F .
VIROLOGY, 1994, 205 (01) :247-253
[7]   DEVELOPMENT OF A QUASI-SPECIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO [J].
CICHUTEK, K ;
MERGET, H ;
NORLEY, S ;
LINDE, R ;
KREUZ, W ;
GAHR, M ;
KURTH, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7365-7369
[8]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[9]  
DICKOVER RE, 1996, JAMA-J AM MED ASSOC, V278, P566
[10]   CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES FROM CHILDREN IN ROMANIA - IDENTIFICATION OF A NEW ENVELOPE SUBTYPE [J].
DUMITRESCU, O ;
KALISH, ML ;
KLIKS, SC ;
BANDEA, CI ;
LEVY, JA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :281-288